These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8554889)

  • 1. [Which equipment for proton therapy of the future?].
    Schwartz LH; Laisne A; Ivanov AA; Mandrillon P; Chauvel P; Mazal A; Habrand JL; Tronc D; Baccal M; Laugier A
    Bull Cancer Radiother; 1995; 82(4):365-9. PubMed ID: 8554889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of proton beams in radiation oncology.
    Loeffler JS; Smith AR; Suit HD
    Semin Oncol; 1997 Dec; 24(6):686-95. PubMed ID: 9422264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of the protons.
    Ma CM; Maughan RL
    Med Phys; 2006 Mar; 33(3):571-3. PubMed ID: 16878559
    [No Abstract]   [Full Text] [Related]  

  • 4. Number of patients potentially eligible for proton therapy.
    Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
    Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of radiotherapy, carbon ion therapy, proton therapy and BNCT in Japan.
    Nakagawa Y; Yoshihara H; Kageji T; Matsuoka R; Nakagawa Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S80-3. PubMed ID: 19394238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton therapy for cancer treatment.
    Dinesh Mayani D
    J Oncol Pharm Pract; 2011 Sep; 17(3):186-90. PubMed ID: 20634263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton beam therapy].
    Ogino T
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):450-4. PubMed ID: 16612152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton therapy, the future of radiotherapy?].
    Schwartz LH; Mazal A; Delacroix S; Schlienger P; Le Nir C; Habrand JL
    Presse Med; 1993 Sep; 22(27):1253-5. PubMed ID: 8259351
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy.
    Smith AR
    Phys Med Biol; 2006 Jul; 51(13):R491-504. PubMed ID: 16790919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cost of radiotherapy].
    Martin P
    Bull Cancer; 2003 Nov; 90(11):969-75. PubMed ID: 14706900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam therapy: too expensive to become true?
    Lievens Y; Van den Bogaert W
    Radiother Oncol; 2005 May; 75(2):131-3. PubMed ID: 15890422
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demand for proton-ray therapy in Russia by 2010].
    Khmelevskiĭ EV
    Vopr Onkol; 2009; 55(4):430-2. PubMed ID: 19947364
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quo vadis, particle therapy?].
    Enghardt W; Hodapp N; Schreiber L; Zink K
    Z Med Phys; 2011 Dec; 21(4):245. PubMed ID: 22075491
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrete event simulation of a proton therapy facility: a case study.
    Corazza U; Filippini R; Setola R
    Comput Methods Programs Biomed; 2011 Jun; 102(3):305-16. PubMed ID: 20675013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Valorisation of high technology radiotherapy in Europe].
    Lievens Y
    Cancer Radiother; 2006 Nov; 10(6-7):361-9. PubMed ID: 17027312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Integrated treatment planning system of proton therapy for deeply seated tumors].
    Inada T; Hayakawa Y; Maruhashi A; Ohara K; Ishikawa N; Kitagawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1047-55. PubMed ID: 3001636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.